Neurodegenerative Diseases News and Research RSS Feed - Neurodegenerative Diseases News and Research

Brainstorm Cell Therapeutics provides business update, announces financial results for 2014

Brainstorm Cell Therapeutics provides business update, announces financial results for 2014

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced financial results for the three months and year ended December 31, 2014. [More]
Immunotherapy reverses memory problems in animal model of Alzheimer's disease

Immunotherapy reverses memory problems in animal model of Alzheimer's disease

A new study from the University of Texas Medical Branch at Galveston has revealed that a single dose of an immunotherapy reverses memory problems in an animal model of Alzheimer's disease. The article appears in the March 25 issue of the Journal of Neuroscience. [More]
Serious head injuries may contribute to faster brain ageing, new study reveals

Serious head injuries may contribute to faster brain ageing, new study reveals

People who have suffered serious head injuries show changes in brain structure resembling those seen in older people, according to a new study. [More]
TxCell to present at upcoming US and French investment conferences

TxCell to present at upcoming US and French investment conferences

Damian Marron, CEO, TxCell, will present at the Alliance for Regenerative Medicine's 3rd Annual Regen Med Investor Day, New York, March 25, 2015. In addition, Damian Marron will also participate at the Portzamparc PEA-PME Forum, Paris, April 1, 2015. [More]
Biologists identify new mechanisms linked to progression of aggressive form of dementia

Biologists identify new mechanisms linked to progression of aggressive form of dementia

Research by biologists at the University of York has identified new mechanisms potentially driving progression of an aggressive form of dementia. [More]
Keystone meeting focuses on neuroinflammation, Alzheimer's and other neurodegenerative diseases

Keystone meeting focuses on neuroinflammation, Alzheimer's and other neurodegenerative diseases

As Alzheimer's disease sweeps through the brain, do the brain's immune cells sit idly by and let it happen? Or could they overreact and make the disease worse? [More]
Discovery can help stop emergence of age-related neurodegenerative diseases

Discovery can help stop emergence of age-related neurodegenerative diseases

As medicine has improved, increasing our ability to treat disease, so our longevity. The deterioration of the body with age, though, is a whole other matter. [More]
Cancer drug promotes neuronal regeneration after spinal cord injury

Cancer drug promotes neuronal regeneration after spinal cord injury

Damage to the spinal cord rarely heals because the injured nerve cells fail to regenerate. The regrowth of their long nerve fibers is hindered by scar tissue and molecular processes inside the nerves. [More]
Non-invasive ultrasound technology can treat Alzheimer's disease, restore memory

Non-invasive ultrasound technology can treat Alzheimer's disease, restore memory

Queensland scientists have found that non-invasive ultrasound technology can be used to treat Alzheimer's disease and restore memory. [More]
Plant molecule helps female mice combat weight gain

Plant molecule helps female mice combat weight gain

A molecule found in some plants can combat weight gain induced by a high-fat diet, but only in female mice, not males. 7,8-dihydroxyflavone (7,8-DHF) is thought to mimic the effects of a growth factor induced by exercise. [More]
Oxytocin may be a potential therapeutic target for improving social function in psychiatric disorders

Oxytocin may be a potential therapeutic target for improving social function in psychiatric disorders

Researchers at the Yerkes National Primate Research Center, Emory University, have shown inducing the release of brain oxytocin may be a viable therapeutic option for enhancing social function in psychiatric disorders, including autism spectrum disorders and schizophrenia. [More]
Henry Ford researchers propose new treatment strategy for stroke, other neurological disorders

Henry Ford researchers propose new treatment strategy for stroke, other neurological disorders

Medicine should reconsider how it treats stroke and other neurological disorders, focusing on the intrinsic abilities of the brain and nervous system to heal themselves rather than the "modest" benefits of clot-busting drugs and other neuroprotective treatments. [More]
Pollution effect: Potentially toxic microbes pose threat to drinking water

Pollution effect: Potentially toxic microbes pose threat to drinking water

Potentially toxic microbes which pose a threat to our drinking water have undergone a dramatic population explosion over the last 200 years as a result of pollution, research involving experts from The University of Nottingham has found. [More]
Preliminary NIBIB-funded study may improve prediction of mild traumatic brain injury

Preliminary NIBIB-funded study may improve prediction of mild traumatic brain injury

A preliminary study conducted by researchers funded by the National Institute of Biomedical Imaging and Bioengineering may improve our prediction of mild traumatic brain injury (mTBI). Every year more than 40 million people worldwide suffer from mTBI. 3.8 million concussions occur in the US each year during sports and recreation alone. [More]
New skin test may help detect abnormal proteins in patients with Alzheimer's and Parkinson's diseases

New skin test may help detect abnormal proteins in patients with Alzheimer's and Parkinson's diseases

Scientists have discovered a skin test that may shed new light on Alzheimer's and Parkinson's diseases, according to a study released today will be presented at the American Academy of Neurology's 67th Annual Meeting in Washington, D.C., April 18 to 25, 2015. [More]
LSU Health New Orleans finalizes deal with CB BioSciences

LSU Health New Orleans finalizes deal with CB BioSciences

The Office of Technology Management at LSU Health New Orleans has finalized a deal with CB BioSciences, Inc., a startup drug development company to build a platform around the intellectual property portfolio of Chu Chen, PhD, LSU Health New Orleans Professor of Neuroscience. [More]
Neurodegenerative disease research using NMR: an interview with Christian Griesinger

Neurodegenerative disease research using NMR: an interview with Christian Griesinger

Christian Griesinger, director of the NMR-based Structural Biology department at the Max-Planck Institute for Biophysical Chemistry, talks about his research into neurodegenerative diseases using NMR to examine the dynamics of disordered proteins. [More]
Korean scientists produce flexible, stable monolayers of protein-bound gold nanoparticles

Korean scientists produce flexible, stable monolayers of protein-bound gold nanoparticles

Free-standing nanoparticle films are of great interest for technical applications, such as the development of nanoelectronic devices. In the journal Angewandte Chemie, Korean scientists have introduced very flexible and stable monolayers of gold nanoparticles made by a self-assembly process based on protein aggregation. The films were used to coat wafers up to 10 cm in diameter. [More]
Scientists identify role of tau-associated MAPT gene in development of Alzheimer's disease

Scientists identify role of tau-associated MAPT gene in development of Alzheimer's disease

An international team of scientists, led by researchers at the University of California, San Diego School of Medicine, has identified the microtubule-associated protein tau (MAPT) gene as increasing the risk for developing Alzheimer's disease (AD). [More]
TSRI scientists discover novel mechanism involved in Alzheimer's, Parkinson's and ALS

TSRI scientists discover novel mechanism involved in Alzheimer's, Parkinson's and ALS

Scientists from the Florida campus of The Scripps Research Institute have for the first time discovered a killing mechanism that could underpin a range of the most intractable neurodegenerative diseases such as Alzheimer's, Parkinson's and ALS. [More]
Advertisement
Advertisement